The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
Open accessAbstract
Histone-modifying enzymes play essential roles in physiological and aberrant gene regulation. Since histone deacetylases (HDACs) are promising targets of cancer therapy, it is important to understand the mechanisms of HDAC regulation. Selective modulators of HDAC isoenzymes could serve as efficient and well-tolerated drugs. We show that HDAC2 undergoes basal turnover by the ubiquitin-proteasome pathway. Valproic acid (VPA), in addition to selectively inhibiting the catalytic activity of class I HDACs, induces proteasomal degradation of HDAC2, in contrast to other inhibitors such as trichostatin A (TSA). Basal and VPA-induced HDAC2 turnover critically depend on the E2 ubiquitin conjugase Ubc8 and the E3 ubiquitin ligase RLIM. Ubc8 gene expression is induced by both VPA and TSA, whereas only TSA simultaneously reduces RLIM protein levels and therefore fails to induce HDAC2 degradation. Thus, poly-ubiquitination and proteasomal degradation provide an isoenzyme-selective mechanism for downregulation of HDAC2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of histone deacetylase (HDAC) increases acetylation of H4 and disrupts the interaction between the locus and RNA polymerase II, leading to the suppression of PU.1 transcription in murine microglia [35, 36].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [36]
In the citing paper
“Valproic acid treatment, which selectively inhibits the catalytic activity of class I HDACs and induces proteasomal degradation of HDAC2, of primary adult human microglia reduces phagocytic capacity and expression of PU.1 and CD45, suggesting the its regulation of microglial phagocytosis via epigenetic mechanism [36-38].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [36]
In the citing paper
“Acetylation of histone H4 on the promoter and intron-1 region of the PU.1 locus are tightly regulated for allowing the interaction between the locus and RNA polymerase II.”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [36]
In the citing paper
“suggesting the its regulation of microglial phagocytosis via epigenetic mechanism [36-38].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,296
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Göttlicher, M., Minucci, S., Zhu, P., Krämer, O. H., Schimpf, A., Giavara, S., Sleeman, J. P., Coco, F. L., Nervi, C., Pelicci, P. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,930
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,544
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230
Protein regulation by monoubiquitin
Hicke, L. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056583 · Cited by 1,227
A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression
Heinzel, T., Lavinsky, R. M., Mullen, T.-M., Söderström, M., Laherty, C. D., Torchia, J., Yang, W., Brard, G., Ngo, S. D., Davie, J., et al. (1997) · Nature · doi:10.1038/387043a0 · Cited by 1,210
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 522
Cheng, F., Zhao, J., Fooksa, M., & Zhao, Z. (2016) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocw007 · Cited by 57
Zhang, J., Kan, S., Huang, B., Hao, Z., Mak, T. W., & Zhong, Q. (2011) · Genes & Development · doi:10.1101/gad.170605.111 · Cited by 56
Kim, H., Lee, J.-H., Bae, S., Ryoo, H., Kim, H., Ha, H., & Lee, Z. H. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.426 · Cited by 54
Redjal, N., Reinshagen, C., Le, A., Walcott, B. P., McDonnell, E., Dietrich, J., & Nahed, B. V. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2054-8 · Cited by 53
Travaglini, L., Vian, L., Billi, M., Grignani, F., & Nervi, C. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.019 · Cited by 53
Li, M., Zhong, X., He, Z., Wen, M., Li, J., Peng, X., Liu, G., Deng, J., Zhang, J., & Bai, J. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2011.12.022 · Cited by 52
Yagi, Y., Fushida, S., Harada, S., Kinoshita, J., Makino, I., Oyama, K., Tajima, H., Fujita, H., Takamura, H., Ninomiya, I., et al. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-149 · Cited by 53
Malki, K., Du Rietz, E., Crusio, W. E., Pain, O., Paya‐Cano, J., Karadaghi, R. L., Sluyter, F., de Boer, S. F., Sandnabba, K., Schalkwyk, L. C., et al. (2016) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32451 · Cited by 52
Protected from the inside: Endogenous histone deacetylase inhibitors and the road to cancer
Marcotullio, L. D., Canettieri, G., Infante, P., Greco, A., & Gulino, A. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.01.002 · Cited by 51
Chen, J., Zheng, Y., Xu, C., Gu, L.-Z., Ding, Z., Qin, L., Wang, Y., Fu, R., Wan, Y.-F., & Hu, C. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0307 · Cited by 51
Buchwald, M., Pietschmann, K., Brand, P., Günther, A., Mahajan, N. P., Heinzel, T., & Krämer, O. H. (2012) · Oncogene · doi:10.1038/onc.2012.515 · Cited by 50
Ahn, M. Y., Kang, D. O., Na, Y. J., Yoon, S., Choi, W. S., Kang, K. W., Chung, H. Y., Jung, J. H., Min, D. S., & Kim, H. S. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.06.017 · Cited by 52
HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2
Scognamiglio, A., Nebbioso, A., Manzo, F., Valente, S., Mai, A., & Altucci, L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.007 · Cited by 51
Ziauddin, M. F., Yeow, W.-S., Maxhimer, J. B., Baras, A., Chua, A., Reddy, R. M., Tsai, W. S., Cole, G. W., Schrump, D. S., & Nguyen, D. M. (2006) · Neoplasia · doi:10.1593/neo.05823 · Cited by 49
TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels
Makki, M. S., Heinzel, T., & Englert, C. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn356 · Cited by 47
Chomiak, T., & Hu, B. (2012) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.08.005 · Cited by 49
The Epigenetic Modifier, Valproic Acid, Enhances Radiation Sensitivity
Karagiannis, T. C., Kurup, H. K. N., & El‐Osta, A. (2006) · Epigenetics · doi:10.4161/epi.1.3.2896 · Cited by 45
Kumar, P., Tripathi, S., & Pandey, K. N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.511444 · Cited by 45
Kabel, A. M., Omar, M. S., & Elmaaboud, M. A. A. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.08.008 · Cited by 45
Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
Leone, G. G. M., D’Alò, F., Zardo, G., Voso, M. T., & Nervi, C. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708784534947 · Cited by 46
Activation of GATA4 gene expression at the early stage of cardiac specification
Yilbas, A. E., Hamilton, A., Wang, Y., Mach, H., Lacroix, N., Davis, D. R., Chen, J., & Li, Q. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00012 · Cited by 45
Spinal Muscular Atrophy and Therapeutic Prospects
Wirth, B., Brichta, L., & Hahnen, E. (2006) · Progress in molecular and subcellular biology · doi:10.1007/978-3-540-34449-0_6 · Cited by 44
Hou, X., Weng, Y., Wang, T., Ouyang, B., Li, Y., Song, Z., Pan, Y., Zhang, Z., Zou, W., Huang, C., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.026 · Cited by 44
Narkaj, K., Stefanelli, G., Wahdan, M., Azam, A. B., Ramzan, F., Steininger, C. F. D., Walters, B. J., & Zovkic, I. B. (2018) · eNeuro · doi:10.1523/eneuro.0378-18.2018 · Cited by 47
Yi, J., Radosevich, A. J., Stypula‐Cyrus, Y., Mutyal, N. N., Azarin, S. M., Horcher, E., Goldberg, M. J., Bianchi, L., Bajaj, S., Roy, H. K., et al. (2014) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.3.036013 · Cited by 43
Vaccaro, T. D. S., Sorrentino, J. M., Salvador, S., Veit, T. D., Souza, D. O., & Almeida, R. F. (2018) · Behavioral Sciences · doi:10.3390/bs8080075 · Cited by 44
Valproic Acid–Induced Gene Expression through Production of Reactive Oxygen Species
Kawai, Y., & Arinze, I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0814 · Cited by 43
Novel HDAC Inhibitors with Radiosensitizing Properties
Jung, M., Velena, A., Chen, B., Petukhov, P. A., Kozikowski, A. P., & Dritschilo, A. (2005) · Radiation Research · doi:10.1667/rr3345 · Cited by 43
Valproic Acid Causes Proteasomal Degradation of DICER and Influences miRNA Expression
Zhang, Z., Convertini, P., Shen, M., Xu, X. Q., Lemoine, F., de la Grange, P., Andres, D., & Stamm, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082895 · Cited by 43
Brief review on repurposed drugs and vaccines for possible treatment of COVID-19
De, P., Chakraborty, I., Karna, B., & Mazumder, N. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173977 · Cited by 46
Glycogen Synthase Kinase 3 Beta (GSK-3β) as a Therapeutic Target in NeuroAIDS
Dewhurst, S., Maggirwar, S. B., Schifitto, G., Gendelman, H. E., & Gelbard, H. A. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9051-1 · Cited by 42
Sun, X., Li, Z., Zhang, Y., Zhou, G., Zhang, J., Deng, J., Bai, J., Liu, G., Li, M., MacNee, W., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00292.2014 · Cited by 42
Schneider, G., Krämer, O. H., Schmid, R. M., & Saur, D. (2011) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-011-9257-1 · Cited by 42
B56 Regulatory Subunit of Protein Phosphatase 2A Mediates Valproic Acid-Induced p300 Degradation
Chen, J., St‐Germain, J. R., & Li, Q. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.2.525-532.2005 · Cited by 41
Yeow, W.-S., Ziauddin, M. F., Maxhimer, J. B., Shamimi-Noori, S. M., Baras, A., Chua, A., Schrump, D. S., & Nguyen, D. M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603132 · Cited by 40
Valproic acid enhances gene expression from viral gene transfer vectors
Fan, S., Maguire, C. A., Ramirez, S. H., Bradel-Tretheway, B., Sapinoro, R., Sui, Z., Chakraborty‐Sett, S., & Dewhurst, S. (2005) · Journal of Virological Methods · doi:10.1016/j.jviromet.2004.11.023 · Cited by 39
Prestegui-Martel, B., Bermúdez-Lugo, J. A., Chávez-Blanco, A. D., Dueñas‐González, A., García-Sánchez, J. R., Pérez-González, O. A., Martínez, I. I. P., Fragoso-Vázquez, M. J., Mendieta‐Wejebe, J. E., Correa-Basurto, A. M., et al. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1210138 · Cited by 39
Ihlefeld, K., Claas, R. F., Koch, A. H., Pfeilschifter, J. M., & zu Heringdorf, D. M. (2012) · Biochemical Journal · doi:10.1042/bj20120811 · Cited by 39
Gut microbiota shapes social dominance through modulating HDAC2 in the medial prefrontal cortex
Wang, T., Xu, J., Xu, Y., Xiao, J., Bi, N., Gu, X., & Wang, H.-L. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110478 · Cited by 38
Histone Deacetylase 2 Is a Component of Influenza A Virus-Induced Host Antiviral Response
Nagesh, P. T., Hussain, M., Galvin, H. D., & Husain, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01315 · Cited by 37
Rossetti, F., Furtado, M. D. A., Pak, T. K., Bailey, K., Shields, M. C., Chanda, S., Addis, M., Robertson, B. D., Moffett, M. C., Lumley, L. A., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.02.010 · Cited by 38
Cancer Risk in Long-term Users of Valproate: A Population-Based Case-Control Study
Hallas, J., Friis, S., Bjerrum, L., Støvring, H., Narverud, S. F., Heyerdahl, T., Grønbæk, K., & Andersen, M. T. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0646 · Cited by 38
Cytotoxic Triterpenoids from the Stems of Microtropis japonica
Chen, I.-H., Lu, M., Du, Y.-C., Yen, M., Wu, C., Chen, Y., Hung, C.-S., Chen, S., Chang, F., & Wu, Y. (2009) · Journal of Natural Products · doi:10.1021/np800694b · Cited by 38
The proteasome and epigenetics: zooming in on histone modifications
Bach, S. V., & Hegde, A. N. (2016) · BioMolecular Concepts · doi:10.1515/bmc-2016-0016 · Cited by 37
Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas
Erlich, R. B., Rickwood, D., Coman, W. B., Saunders, N. A., & Guminski, A. D. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0747-1 · Cited by 37
Valproic Acid Affects Membrane Trafficking and Cell-Wall Integrity in Fission Yeast
Miyatake, M., Kuno, T., Kita, A., Katsura, K., Takegawa, K., Uno, S., Nabata, T., & Sugiura, R. (2007) · Genetics · doi:10.1534/genetics.107.070946 · Cited by 37
Histone deacetylases are required for amphibian tail and limb regeneration but not development
Taylor, A. J., & Beck, C. W. (2012) · Mechanisms of Development · doi:10.1016/j.mod.2012.08.001 · Cited by 38
Valproate enhances imatinib‐induced growth arrest and apoptosis in chronic myeloid leukemia cells
Morotti, A., Cilloni, D., Messa, F., Arruga, F., Defilippi, I., Carturan, S., Catalano, R., Rosso, V., Chiarenza, A., Pilatrino, C., et al. (2006) · Cancer · doi:10.1002/cncr.21725 · Cited by 36
Roles of miR-138 and ISG15 in oral squamous cell carcinoma
Zhang, Q., He, Y., Nie, M., & Cai, W. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4720 · Cited by 35
Patel, M. M., & Patel, B. M. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.05.026 · Cited by 36
Acute leukemia associated with valproic acid treatment: A novel mechanism for leukemogenesis?
Coyle, T., Bair, A. K., Stein, C. K., Vajpayee, N., Mehdi, S. B., & Wright, J. (2005) · American Journal of Hematology · doi:10.1002/ajh.20273 · Cited by 36
Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice
Krepulat, F., Löhler, J., Heinlein, C., Hermannstädter, A., Tolstonog, G. V., & Deppert, W. (2005) · Oncogene · doi:10.1038/sj.onc.1208557 · Cited by 34
Ouyang, B., Chen, D., Hou, X., Wang, T., Wang, J., Zou, W., Song, Z., Huang, C., Guo, Q., & Weng, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00346 · Cited by 33
Lochmanová, G., Ihnatová, I., Kuchaříková, H., Brabencová, S., Zachová, D., Fajkus, J., Zdráhal, Z., & Fojtová, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205093 · Cited by 34
Borgonetti, V., & Galeotti, N. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105431 · Cited by 35
Du, Y., Lin, J., Zhang, R., Yang, W., Quan, H., Zang, L., Han, Y., Li, B., Sun, H., & Wu, J. (2019) · Aging · doi:10.18632/aging.102425 · Cited by 33
Potential of chromatin modifying compounds for the treatment of Alzheimer's disease
Karagiannis, T. C., & Ververis, K. (2012) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v2i0.14980 · Cited by 34
Frints, S. G. M., Ozantürk, A., Criado, G. R., Grasshoff, U., de Hoon, B., Field, M. J., Manouvrier‐Hanu, S., Hickey, S. E., Kammoun, M., Gripp, K. W., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0065-x · Cited by 34
HAT and HDAC: Enzyme with Contradictory Action in Neurodegenerative Diseases
Singh, R., Rathore, A. S., Dilnashin, H., Keshri, P. K., Gupta, N. K., Satyaprakash, S. A., Zahra, W., Singh, S., & Singh, S. P. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04115-6 · Cited by 31
Quigley, R. M., Kearney, M., Kennedy, O. D., & Duncan, H. F. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.06.012 · Cited by 38
Fujiki, R., Sato, A., Fujitani, M., & Yamashita, T. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.205 · Cited by 32
Coronel, J., Klausing, S., Heinrich, C., Noll, T., Figueredo‐Cardero, A., & Castilho, L. R. (2016) · Biochemical Engineering Journal · doi:10.1016/j.bej.2016.06.031 · Cited by 34
Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification
Kwon, D., Ryu, J., Kim, Y., & Kook, H. Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093246 · Cited by 32
Tsai, H., Wei, K., Chen, P., Huang, C.-Y., Chen, K., Lin, Y.-J., Cheng, H.-W., Chen, Y.-R., & Wang, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.722754 · Cited by 33
Baumann, C., Zhang, X., Zhu, L., Fan, Y., & Fuente, R. D. L. (2021) · Epigenetics & Chromatin · doi:10.1186/s13072-021-00432-5 · Cited by 33
SEURAT-1 liver gold reference compounds: a mechanism-based review
Jennings, P., Schwarz, M., Landesmann, B., Maggioni, S., Γούμενου, Μ., Bower, D., Leonard, M. O., & Wiseman, J. S. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1410-8 · Cited by 35
Zutz, C., Bandian, D., Neumayer, B., Speringer, F., Gorfer, M., Wagner, M., Strauss, J., & Rychli, K. (2014) · BioMed Research International · doi:10.1155/2014/540292 · Cited by 32
Talwadekar, M., Fernandes, S., Kale, V. P., & Limaye, L. S. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2219 · Cited by 32
Ouyang, D., Zhang, Y.-T. Y., Xu, L., Li, J., Zha, Q., & He, X. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr032 · Cited by 31
Ubiquitin Regulation: The Histone Modifying Enzyme′s Story
Wang, J., Qiu, Z., & Wu, Y. (2018) · Cells · doi:10.3390/cells7090118 · Cited by 32
Kim, Y. K., Seo, D. W., Kang, D. W., Lee, H. Y., Han, J., & Kim, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.196 · Cited by 31
Rücker, F. G., Lang, K. M. H., Fütterer, M., Komarica, V., Schmid, M., Döhner, H., Schlenk, R. F., Döhner, K., Knudsen, S., & Bullinger, L. (2016) · Epigenetics · doi:10.1080/15592294.2016.1187350 · Cited by 31
Kwon, K. J., Kim, J. N., Kim, M. K., Kim, S., Cho, K. S., Jeon, S. J., Kim, H. Y., Ryu, J. H., Han, S., Cheong, J. H., et al. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.019 · Cited by 30
HDAC2 Inhibitor Valproic Acid Increases Radiation Sensitivity of Drug-Resistant Melanoma Cells
Kalal, B. S., Pai, V. R., Behera, S. K., & Somashekarappa, H. M. (2019) · Medical Sciences · doi:10.3390/medsci7030051 · Cited by 30
Cho, D., Park, J., Lee, E. J., Won, K., Lee, S., Kim, Y.-H., Hwang, S., Kwon, K. J., Shin, C. Y., Song, K., et al. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.043 · Cited by 31
Paternal RLIM/Rnf12 Is a Survival Factor for Milk-Producing Alveolar Cells
Jiao, B., Ma, H., Shokhirev, M. N., Drung, A., Yang, Q., Shin, J., Lu, S., Byron, M., Kalantry, S., Mercurio, A. M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.056 · Cited by 31
Kaler, P., Sasazuki, T., Shirasawa, S., Augenlicht, L. H., & Klampfer, L. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.01.010 · Cited by 32
Zápotocký, M., Mejstříková, E., Smetana, K., Starý, J., Trka, J., & Starková, J. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.041 · Cited by 29
Marx, N., Eisenhut, P., Weinguny, M., Klanert, G., & Borth, N. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.107924 · Cited by 30
Savickienė, J., Treigytė, G., Borutinskaite, V. V., & Navakauskienė, R. (2012) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-012-0024-5 · Cited by 29
Loss of CFTR results in reduction of histone deacetylase 2 in airway epithelial cells
Bartling, T. R., & Drumm, M. L. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90399.2008 · Cited by 29
The Role of HDACs Inhibitors in Childhood and Adolescence AcuteLeukemias
Masetti, R., Serravalle, S., Biagi, C., & Pession, A. (2011) · BioMed Research International · doi:10.1155/2011/148046 · Cited by 29
Kwiecińska, P., Wróbel, A. M., Taubøll, E., & Gregoraszczuk, E. Ł. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.10.035 · Cited by 29
Michaelis, M., Köhler, N., Reinisch, A., Eikel, D., Gravemann, U., Doerr, H. W., Nau, H., & Cinatl, J. J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.013 · Cited by 30
Valproate reverses mania-like behaviors in mice via preferential targeting of HDAC2
Logan, R. W., Ozburn, A. R., Arey, R. N., Ketchesin, K. D., Winquist, A., Crain, A., Tobe, B. T. D., Becker‐Krail, D. D., Jarpe, M. B., Xue, X., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00958-2 · Cited by 29
Fujimura, K., Mitsuhashi, T., & Takahashi, T. (2017) · Brain and Development · doi:10.1016/j.braindev.2017.03.026 · Cited by 27
Jiao, B., Taniguchi-Ishigaki, N., Güngör, C., Peters, M. A., Chen, Y., Riethdorf, S., Drung, A., Ahronian, L. G., Shin, J., Pagnis, R., et al. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-05-0239 · Cited by 28
Aarenstrup, L., Flindt, E. N., Otkjær, K., Kirkegaard, M., Andersen, J., & Kristiansen, K. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701146 · Cited by 27
Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation
Aher, J., Khan, S., Jain, S., Tikoo, K., & Jena, G. (2014) · Human & Experimental Toxicology · doi:10.1177/0960327114531992 · Cited by 27
Histone Deacetylases and Their Role in Asthma
Royce, S. G., & Karagiannis, T. C. (2012) · Journal of Asthma · doi:10.3109/02770903.2011.648298 · Cited by 27
Histone deacetylase inhibition redistributes topoisomerase IIb from heterochromatin to euchromatin
Cowell, I. G., Papageorgiou, N., Padget, K., Watters, G. P., & Austin, C. A. (2011) · Nucleus · doi:10.4161/nucl.14194 · Cited by 27
Kosan, C., Ginter, T., Heinzel, T., & Krämer, O. H. (2013) · JAK-STAT · doi:10.4161/jkst.26102 · Cited by 26
Criss‐crossing autism spectrum disorder and adult neurogenesis
Bicker, F., Nardi, L., Maier, J., Vasić, V., & Schmeißer, M. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15501 · Cited by 26
Redox-sensitive gene-regulatory events controlling aberrant matrix metalloproteinase-1 expression
Bartling, T. R., Subbaram, S., Clark, R. R., Chandrasekaran, A., Kar, S., & Melendez, J. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.017 · Cited by 26
Akgün, O., Erkısa, M., & Arı, F. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28813 · Cited by 26
Wu, P., Tian, Y. E., Chen, G., Wang, B., Gui, L., Xi, L., Ma, X., Fang, Y., Zhu, T., Wang, D., et al. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.142 · Cited by 26
Endo, T., Kanô, K., & Naito, K. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.107.067397 · Cited by 26
Makhwitine, J. P., Kumalo, H. M., Ndlovu, S. I., & Mkhwanazi, N. P. (2023) · Microorganisms · doi:10.3390/microorganisms11061404 · Cited by 25
Differential regulation of PML–RARα stability by the ubiquitin ligases SIAH1/SIAH2 and TRIAD1
Pietschmann, K., Buchwald, M., Müller, S., Knauer, S. K., Koegl, M., Heinzel, T., & Krämer, O. H. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.008 · Cited by 25
Effect of small molecules on cell reprogramming
Baranek, M., Belter, A., Naskręt-Barciszewska, M. Z., Stobiecki, M., Markiewicz, W. T., & Barciszewski, J. (2016) · Molecular BioSystems · doi:10.1039/c6mb00595k · Cited by 25
Metadata
- Authors
- Krämer, O. H., Zhu, P., Ostendorff, H. P., Golebiewski, M., Tiefenbach, J., Peters, M. A., Brill, B., Groner, B., Bach, I., Heinzel, T., & Göttlicher, M.
- Affiliations
- Georg Speyer Haus (DE)
- Universität Hamburg (DE)
- Corresponding author
- Heinzel, Thorsten
- Göttlicher, Martin
- Venue
- The EMBO Journal
- Published
- 2003-07-01
- Volume
- 22
- Issue
- 13
- Pages
- 3411-3420
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC165640
- OpenAlex
- W2106775330
- Cited by
- 523
- References
- 41
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 14 · 2023: 13 · 2022: 25 · 2021: 16 · 2020: 19 · 2019: 20 · 2018: 27 · 2017: 26 · 2016: 30 · 2015: 19 · 2014: 27 · 2013: 33 · 2012: 29
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- valproic acid, HDAC2, histone deacetylase inhibitors, proteasomal degradation, ubiquitin-proteasome system, RLIM, polyubiquitination, trichostatin A, class I HDACs, protein turnover
- MeSH terms
- Animals, Base Sequence, Cells, Cultured, Cysteine Endopeptidases, Enzyme Inhibitors, Female, Hydrolysis, Hydroxamic Acids, Multienzyme Complexes, Valproic Acid, DNA Primers, Ubiquitin, Proteasome Endopeptidase Complex, Mice, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
